Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 18/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13507834 | 0.91 | KDM4E (0.32) | PDK2KDM4EMAPK1ATM | |
| SCHEMBL25843053 | 0.89 | MAPK1 (0.53) | PDK2KDM4EMAPK1ATM | |
| SCHEMBL19600422 | 0.87 | KDM4E (0.37) | PDK2KDM4EMAPK1ATM | |
| SCHEMBL16017949 | 0.87 | PDK2 (0.38) | PDK2 | |
| SCHEMBL25875723 | 0.87 | PDK2 (0.37) | PDK2KDM4EMAPK1ATM | |
| SCHEMBL13507805 | 0.86 | PDK2 (0.34) | PDK2 | |
| SCHEMBL18159610 | 0.84 | PDK2 (0.38) | PDK2ATM | |
| SCHEMBL25849430 | 0.84 | PDK2 (0.38) | PDK2 | |
| SCHEMBL25868886 | 0.83 | KDM4E (0.39) | PDK2KDM4EMAPK1ATM | |
| SCHEMBL19600433 | 0.83 | KDM4E (0.46) | PDK2KDM4EMAPK1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | PDK2 1690/4885KDM4E 3009/4885MAPK1 763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.